Vergoeding 2019-2023 voor ATC-subgroep J05AX : Overige antivirale middelen
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| J05AX09 Maraviroc (Celsentri ®) | 742.590 | 711.010 | 615.040 | 570.530 | 560.410 |
| J05AX18 Letermovir (Prevymis ®) | 380.120 | 1.068.400 | 1.833.000 | 2.700.200 | 3.350.800 |
| J05AX29 Fostemsavir (Rukobia ®) | . | . | . | 35.340 | 65.569 |
| J05AX31 Lenacapavir (Sunlenca ®) | . | . | . | . | 62.834 |
| Totaal | 1.122.710 | 1.779.410 | 2.448.040 | 3.306.070 | 4.039.613 |